Polished AI pitches flood healthcare leaders’ inboxes, each promising clinical, financial and workforce gains. The hard part isn’t finding AI — it’s deciding which investments will actually move the needle, then implementing them so the results stick.
In a recent Becker’s Healthcare advisory call, C-suite leaders from health systems across the country shared how they separate AI worth funding from the “shiny object.” Their discussion produced a clear five-stage model that carries an investment from problem definition through systemwide scale, anchored by one rule: if it can’t show measurable ROI, it doesn’t move forward.
That return isn’t always direct revenue. It can surface as reclaimed clinician time, stronger provider retention or faster cash flow — as long as the value is measurable and mapped to what each stakeholder cares about.
This report is a practical guide to AI decision-making, grounded in the experience of executives making these calls right now under real margin pressure.
Inside, you’ll find:
- How to tell which AI investments will move the needle and which pitches to skip
- The five stages that carry an AI initiative from pilot to systemwide scale
- Why measurable ROI, not novelty, should gate every AI decision
- How to keep unvetted “shadow AI” from spreading across your organization